Rocket Pharmaceuticals (RCKT) Amortizatization of Intangibles (2016 - 2025)
Rocket Pharmaceuticals (RCKT) has disclosed Amortizatization of Intangibles for 9 consecutive years, with $1.2 million as the latest value for Q4 2025.
- Quarterly Amortizatization of Intangibles fell 1.23% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Dec 2025, down 9.67% year-over-year, with the annual reading at $7.3 million for FY2025, 9.67% down from the prior year.
- Amortizatization of Intangibles hit $1.2 million in Q4 2025 for Rocket Pharmaceuticals, down from $1.7 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.3 million in Q4 2023 to a low of -$744000.0 in Q3 2021.
- Historically, Amortizatization of Intangibles has averaged $1.3 million across 5 years, with a median of $1.5 million in 2024.
- Biggest five-year swings in Amortizatization of Intangibles: crashed 486.29% in 2021 and later skyrocketed 1560.9% in 2023.
- Year by year, Amortizatization of Intangibles stood at $753000.0 in 2021, then soared by 43.56% to $1.1 million in 2022, then skyrocketed by 202.96% to $3.3 million in 2023, then crashed by 62.66% to $1.2 million in 2024, then decreased by 1.23% to $1.2 million in 2025.
- Business Quant data shows Amortizatization of Intangibles for RCKT at $1.2 million in Q4 2025, $1.7 million in Q3 2025, and $2.2 million in Q2 2025.